Mary K. Webster

Light-adjustable lens in eyes with a history of radial keratotomy

Mary K. Webster, Brandon J. Baartman, Marlee Jones, Daniel C. Terveen et autres

PURPOSE: To evaluate visual and refractive outcomes in eyes with a history of radial keratotomy (RK) implanted with the second-generation light-adjustable lens (LAL). SETTING: Private practice, multiple locations. DESIGN: Retrospective, consecutive case series. METHODS: Eyes with a history of RK that underwent …

us (code pays fourni par la source)

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Janet T. Holbrook, Elizabeth A. Sugar, Alyce E. Burke, Albert T. Vitale et autres

us (code pays fourni par la source)

Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial

Michael M. Altaweel, James P. Dunn, Susan Lightman, Jennifer E. Thorne et autres

us, gb (code pays fourni par la source)

Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials

Philip J. Rosenfeld, Howard Shapiro, Lisa L. Tuomi, Mary K. Webster et autres

us (code pays fourni par la source)

Dealkylation of chemical weapon agents and pesticides with group 13 salen compounds

Rahul R. Butala, Joshua K. Cooper, Amithaba Mitra, Mary K. Webster et autres

Group 13 chelates incorporating boron and aluminum deactivated the chemical warfare agents (CWAs) VX, sarin (GB), soman (GD), and the pesticide, diazinon, under mild conditions. The deactivation occured through elimination of alkyl bromide resulting in solid products containing a robust Al-O-P or …

us (code pays fourni par la source)

Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2

Jane Armstrong, Mary K. Webster, Amitha Domalpally, Ronald P. Danis et autres

us (code pays fourni par la source)

Lesion Characteristics in Ranibizumab (LUCENTIS®) Treated Patients With a Visual Acuity (VA) Gain or Loss in the MARINA and ANCHOR Trials for Wet Age-Related Macular Degeneration (AMD)

Philip J. Rosenfeld, Howard Shapiro, Lisa L. Tuomi, Mary K. Webster et autres

us (code pays fourni par la source)

Angiographic Results of the ANCHOR Study of Ranibizumab in Neovascular Age-Related Macular Degeneration: Reading Center Evaluation of Angiographic Data

Mary K. Webster, B. A. Blodi, J.A. Elledge, Ronald P. Danis

us (code pays fourni par la source)

Serous Sensory Retinal Detachment as Measured by Photography and OCT in Neovascular AMD

J.A. Elledge, Mary K. Webster, B. A. Blodi, Ronald P. Danis

us (code pays fourni par la source)

Assessing AMD With Optical Coherence Tomography (OCT): Fast Macular Thickness Maps versus High Resolution Macular Thickness Maps

Rainer Timm, Michael M. Altaweel, Anne Goulding, Mary K. Webster et autres

us (code pays fourni par la source)

Ranibizumab (LucentisTM) in Subjects With Predominantly Classic CNV: Reading Center Evaluation of Angiographic Eligibility Characteristics and Baseline Fluorescein Angiographic Data

S. Glaeser Alexander, B. A. Blodi, Mary K. Webster, J.A. Elledge et autres

us (code pays fourni par la source)

Ranibizumab (LucentisTM) in Subjects With Minimally Classic or Occult CNV (MARINA): Reading Center Evaluation of Angiographic Eligibility Characteristics and Baseline Fluorescein Angiographic Data

Mary K. Webster, B. A. Blodi, S. Glaeser Alexander, J.A. Elledge et autres